Invitae Expands Genome Network Via AltaVoice Acquisition

Invitae, one of the fastest growing genetic information companies, said it acquired AltaVoice, a privately owned, patient-centered data company with a global platform for collecting, curating and delivering safeguarded data from patients and clinicians.

The acquisition, complemented by several other unique partnerships, expands Invitae’s Genome Network, designed to connect patients, clinicians, and therapeutic developers to accelerate the understanding, diagnosis, and treatment of hereditary disease.

In a separate statement, Invitae announced initial Q4 and full-year 2016 results, showing 200% year-over-year growth in billable test volume, driven by milestones including a major expansion of its test menu to more than 1,100 genes and agreements with the nation’s largest payers to provide coverage for more than 175 million lives in aggregate.

For the year, Invitae met its volume guidance of 50,000-70,000 billable tests, delivering approximately 57,000 billable tests in 2016 and roughly tripling the approximately 19,000 billable tests delivered in 2015.

Leave a Comment